| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |